FDA Adverse Event Injury Summary report: N

ILET BIONIC PANCREAS

MDR report key: 21627441 · Received March 17, 2025

Report

Report Number
3019004087-2025-00219
Event Type
Injury
Date Received
March 17, 2025
Date of Event
February 19, 2025
Report Date
March 17, 2025
Manufacturer
BETA BIONIC, INC.
Product Code
QFG
UDI-DI
850050080015
PMA / PMN Number
K231485
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AT THE TIME OF THIS REPORT THE ILET EVALUATION IS STILL IN PROGRESS. A SUPPLEMENTAL REPORT SHALL BE SUBMITTED ONCE THE INVESTIGATION IS COMPLETED.

Description of Event or Problem · 0

ON 21-FEB-2025, THE MANUFACTURER WAS NOTIFIED THAT A USER EXPERIENCED SEVERE HYPOGLYCEMIA ON (B)(6) 2025, RESULTING IN WEAKNESS, COLDNESS, SHAKINESS, AND LETHARGY. THE USER'S BLOOD GLUCOSE (BG) DROPPED TO 39 MG/DL AND REMAINED "LOW" (UNDER 54 MG/DL) FOR APPROXIMATELY NINE HOURS. THE USER ATTEMPTED TO OBTAIN ORANGE JUICE (OJ) BUT WAS TOO WEAK TO MOVE AND CALLED A NEIGHBOR, WHO THEN CONTACTED THE USER'S CHILDREN. EMS ARRIVED, ADMINISTERED OJ, AND TRANSPORTED THE USER TO THE EMERGENCY ROOM (ER). THE USER WAS GIVEN ORAL GLUCOSE AT THE HOSPITAL AND DISCHARGED ONCE BG LEVELS INCREASED. THE USER REPORTED THAT THE DEXCOM G7 CONTINUOUS GLUCOSE MONITOR (CGM) DID ALERT FOR LOW BG DURING THE EVENT. NO LONG-TERM HEALTH EFFECTS WERE REPORTED, AND THE USER RESUMED USE OF THE ILET FOLLOWING THE INCIDENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
884672 ILET BIONIC PANCREAS ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP QFG BETA BIONIC, INC. BB1001 850050080015

Patients

Seq Age Sex Outcome Treatment
1 64 YR Male Required Intervention DEXCOM G7 CONTINUOUS GLUCOSE MONITOR